Q3 2025 Earnings Call Transcript March 11, 2025 Champions Oncology, Inc. beats earnings expectations. Reported EPS is $0.3181 ...

As of 2:16:08 PM EDT. Market Open. HACKENSACK, NJ / ACCESS Newswire / March 11, 2025 / Champions Oncology, Inc. (Nasdaq:CSBR), a global preclinical and clinical research services provider that ...

Craig-Hallum analyst Matt Hewitt reiterated a Buy rating on Champions Oncology (CSBR – Research Report) today. The company’s shares closed last ...

Champions Oncology , Inc. (NASDAQ:CSBR) stock soared to a 52-week high, reaching $10.91, marking a significant milestone for the company specializing in advanced technology solutions and services ...

CHAMPIONS ONCOLOGY ($CSBR) is expected to release its quarterly earnings data on Tuesday, March 11th before market open, per Finnhub. Analysts are expecting revenue ...

So, the natural question for Champions Oncology (NASDAQ:CSBR) shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn as ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Champions Oncology is listed on the CBOE trading with ticker code CSBR.US. It has a market capitalisation of $152.98m, with approximately 13.82m shares in issue. Over the last year, Champions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...